Mass spectrometry in high-throughput proteomics: ready for the big time
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mass spectrometry has evolved and matured to a level where it is able to assess the complexity of the human proteome. We discuss some of the expected challenges ahead and promising strategies for success.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While there have been remarkable advances in quantitative mass spectrometry (Nilsson et al., 2010), it is difficult to match the large dynamic range and comprehensive nature of deep sequencing.”
From Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes (2011) · cites this paper as Nilsson et al., 2010
In the citing paper
“Proper procedures in sample collection, sample preparation, MS experiments and data analysis are all critical to obtain high-quality data for hypothesis-driven or proteome-wide discovery research (Nilsson et al., 2010).”
From Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases (2016) · cites this paper as Nilsson et al., 2010
In the citing paper
“Thus, proteomics is positioned to define the functional roles of proteins in normal and disease-related cellular processes, and to enable hypothesis-driven and discovery research of human diseases (Nilsson et al., 2010).”
From Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases (2016) · cites this paper as Nilsson et al., 2010
In the citing paper
“Again, with regard to large-scale proteome quantification (i.e., 4000+ proteins) across laboratories in >200 measurements, these findings are unprecedented and have evolved to a level where many of the previously described limitations of data acquisition in MS-based proteomics62 are being significantly overcome.”
From Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry (2017) · cites this paper as [62]
In the citing paper
“Mass spectrometry (MS)–based methods continue to be the most widely used methods for high-throughput proteomics research1–4”
From Recent trends of capillary electrophoresis‐mass spectrometry in proteomics research (2019) · cites this paper as [3]
Citations
Cites
Finishing the euchromatic sequence of the human genome
International Human Genome Sequencing Consortium (2004) · Nature · doi:10.1038/nature03001 · Cited by 4,971
Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling
Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S., & Weissman, J. S. (2009) · Science · doi:10.1126/science.1168978 · Cited by 3,853
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Molecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373
A vision for the future of genomics research
Collins, F. S., Green, E. D., Guttmacher, A. E., Guyer, M. S., & on behalf of the US National Human Genome Research Institute (2003) · Nature · doi:10.1038/nature01626 · Cited by 1,752
Absolute Quantification of Proteins by LCMSE
Silva, J. C., Gorenstein, M. V., Li, G.-Z., Vissers, J. P. C., & Geromanos, S. J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500230-mcp200 · Cited by 1,529
Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A.-J. L., Keshishian, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1546 · Cited by 1,037
Desiere, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj040 · Cited by 910
Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast
de Godoy, L. M. F., Olsen, J. V., Cox, J., Nielsen, M. L., Hubner, N. C., Fröhlich, F., Walther, T. C., & Mann, M. (2008) · Nature · doi:10.1038/nature07341 · Cited by 873
Self-citationKrüger, M., Moser, M., Ussar, S., Thievessen, I., Luber, C. A., Forner, F., Schmidt, S., Zanivan, S., Fässler, R., & Mann, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.033 · Cited by 680
Self-citation
Cited by
Items 201–300 of 489
Cayer, D. M., Nazor, K. L., & Schork, N. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw214 · Cited by 29
“These methods do work quite well, but sample preparation, and analysis of MS spectra can often time lead to differing results depending on the personnel or lab that performs the experiment (40).”
BackgroundMass Spectrometry-Based Proteomics
DiFalco, M. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7804-5_9 · Cited by 25
Flexible and Fast Mapping of Peptides to a Proteome with ProteoMapper
Mendoza, L., Deutsch, E. W., Sun, Z., Campbell, D. S., Shteynberg, D. D., & Moritz, R. L. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00544 · Cited by 23
The impact of blood on liver metabolite profiling – a combined metabolomic and proteomic approach
Ly-Verdú, S., Schäfer, A., Kahle, M., Groeger, T. M., Neschen, S., Arteaga-Salas, J. M., Ueffing, M., de Angelis, M. H., & Zimmermann, R. (2013) · Biomedical Chromatography · doi:10.1002/bmc.3010 · Cited by 28
Kojima, K., Bowersock, G. J., Kojima, C., Klug, C. A., Grizzle, W. E., & Mobley, J. A. (2012) · PROTEOMICS · doi:10.1002/pmic.201100663 · Cited by 25
Orton, D. J., & Doucette, A. A. (2013) · Proteomes · doi:10.3390/proteomes1020109 · Cited by 26
“technologies [33–39] can be applied to investigate changes in in vitro or in vivo models of disease, or to profile clinical (human) samples to uncover biomarkers.”
BackgroundProteomic profiling of high risk medulloblastoma reveals functional biology
Staal, J. A., Lau, L. S., Zhang, H., Ingram, W. J., Hallahan, A. R., Northcott, P. A., Pfister, S. M., Wechsler‐Reya, R. J., Rusert, J. M., Taylor, M. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3927 · Cited by 34
“Recent advances in mass spectrometry (MS) technology have improved protein identification and quantitation due to increased sensitivity, accuracy and speed of analysis [7-9].”
Bladergroen, M. R., Derks, R. J. E., Nicolardi, S., de Visser, B., van Berloo, S., van der Burgt, Y. E. M., & Deelder, A. M. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.07.023 · Cited by 23
“Such a high-throughput workflow consists of robust and relatively fast sample processing and preparation (resulting in a reduced complexity) as well as automatedMS [1,12].”
BackgroundChang, C., Zhang, J., Han, M., Ma, J., Zhang, W., Wu, S., Liu, K., Xie, H., He, F., & Zhu, Y. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt726 · Cited by 23
Schilling, J., Nepomuceno, A. I., Schaff, J. E., Muddiman, D. C., Daniels, H. V., & Reading, B. J. (2014) · Journal of Proteome Research · doi:10.1021/pr401067g · Cited by 24
DEEPN as an Approach for Batch Processing of Yeast 2-Hybrid Interactions
Pashkova, N., Peterson, T. A., Krishnamani, V., Breheny, P. J., Stamnes, M. A., & Piper, R. C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.095 · Cited by 23
Sample preparation in foodomic analyses
Martinović, T., Gajdošik, M. Š., & Josić, D. (2018) · Electrophoresis · doi:10.1002/elps.201800029 · Cited by 24
Greening, D. W., Kapp, E. A., & Simpson, R. J. (2017) · The Enzymes · doi:10.1016/bs.enz.2017.08.003 · Cited by 23
A decade of proteomics studies of glaucomatous neurodegeneration
Tezel, G. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300115 · Cited by 22
Chen, C., Liu, X., Zheng, W., Zhang, L., Yao, J., & Yang, P. (2014) · Journal of Proteome Research · doi:10.1021/pr4010986 · Cited by 22
Cancer heterogeneity determined by functional proteomics
Szász, A. M., Győrffy, B., & Marko‐Varga, G. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.026 · Cited by 22
van der Burgt, Y. E. M., & Cobbaert, C. M. (2018) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2018.05.001 · Cited by 22
“An inherent effect was that the focus switched to the number of protein IDs and that isoforms were not considered anymore [12].”
BackgroundTargeted Proteomics Comes to the Benchside and the Bedside: Is it Ready for Us?
Arora, A., & Somasundaram, K. (2019) · BioEssays · doi:10.1002/bies.201800042 · Cited by 22
Zhao, X., Huffman, K. E., Fujimoto, J., Canales, J. R., Girard, L., Nie, G., Heymach, J. V., Wistuba, I. I., Minna, J. D., & Yu, Y. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1706-z · Cited by 25
“Recent advances in mass spectrometry (MS) have enabled quantitative proteome analysis in tissue with high reproducibility, sensitivity, and accuracy in a comparatively short time [21].”
BackgroundQu, J., Young, R. F., Page, B. J., Shen, X., Tata, N., Li, J., Duan, X., Fallavollita, J. A., & Canty, J. M. (2014) · Journal of Proteome Research · doi:10.1021/pr5000472 · Cited by 21
Li, X., Luo, T., Yan, H., Xie, L., Yang, Y., Gong, L., Tang, Z., Tang, M., Zhang, X., Huang, J., et al. (2023) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01573-w · Cited by 21
“Second, because MS is not an ideal technique for quantifying cytokines, most of which have low molecular weight and provide few peptides for MS detection [30, 31], we could not validate previous findings regarding the diagnostic value of cytokines for HLH (e.g., IFN-γ, CXCL9, IL6, and IL-10 [4, 8]).”
ResultFinoulst, I., Vink, P. M., Rovers, E., Pieterse, M., Pinkse, M. W. H., Bos, E. S., & Verhaert, P. D. E. M. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.03.034 · Cited by 21
“[9] Nilsson T, Mann M, Aebersold R, Yates 3rd JR, Bairoch A, Bergeron JJ.”
BackgroundTechnologies and Approaches to Elucidate and Model the Virulence Program of Salmonella
McDermott, J., Yoon, H., Nakayasu, E. S., Metz, T., Hyduke, D. R., Kidwai, A. S., Palsson, B. Ø., Adkins, J., & Heffron, F. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00121 · Cited by 21
pyQms enables universal and accurate quantification of mass spectrometry data
Leufken, J., Niehues, A., Sarin, L. P., Wessel, F., Hippler, M., Leidel, S. A., & Fufezan, C. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m117.068007 · Cited by 24
“proteomics (44), especially if one takes the mScore as a”
BackgroundMapping the Small Molecule Interactome by Mass Spectrometry
Flaxman, H. A., & Woo, C. M. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b01038 · Cited by 22
Byrling, J., Kristl, T., Hu, D., Plá, I., Sánchez, A., Sasor, A., Andersson, R. E., Marko‐Varga, G., & Andersson, B. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02498-3 · Cited by 21
Proteomic Analysis Reveals Innate Immune Activity in Intestinal Transplant Dysfunction
Kumar, A. R., Li, X., LeBlanc, J. F., Farmer, D. G., Elashoff, D. A., Braun, J. G., & Ziring, D. (2011) · Transplantation · doi:10.1097/tp.0b013e31821d262b · Cited by 21
“This technology has been successfully applied to profile proteins from different forms of clinical specimens (16), and protein combinations provide potentially innovative biomarkers which are useful in diagnosis or disease monitoring.”
MethodThreshold-Avoiding Proteomics Pipeline
Suits, F., Hoekman, B., Rosenling, T., Bischoff, R., & Horvatovich, P. L. (2011) · Analytical Chemistry · doi:10.1021/ac201332j · Cited by 21
Sciuto, M. R., Warnken, U. H., Schnölzer, M., Valvo, C., Brunetto, L., Boe, A., Biffoni, M., Krammer, P. H., Maria, R. D., & Haas, T. L. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o116.065920 · Cited by 21
“one of the major objectives in cell biology and especially in proteome research (1).”
BackgroundMass-Spectrometry-Based Near-Complete Draft of the Saccharomyces cerevisiae Proteome
Gao, Y., Ping, L., Duong, D. M., Zhang, C., Dammer, E. B., Li, Y., Chen, P., Chang, L., Gao, H., Wu, J., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00721 · Cited by 20
jTraML: An Open Source Java API for TraML, the PSI Standard for Sharing SRM Transitions
Helsens, K., Brusniak, M., Deutsch, E. W., Moritz, R. L., & Martens, L. (2011) · Journal of Proteome Research · doi:10.1021/pr200664h · Cited by 20
Advances in Urinary Proteome Analysis and Applications in Systems Biology
Filip, S. K., Zoidakis, J., Vlahou, A., & Mischak, H. (2014) · Bioanalysis · doi:10.4155/bio.14.210 · Cited by 21
Tyrosine–EDC Conjugation, an Undesirable Side Effect of the EDC-Catalyzed Carboxyl Labeling Approach
Li, Q., Zhang, Y., Wu, Z., Huang, J., Yue, N., Huang, L., & Zhang, X. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03487 · Cited by 20
Transcriptomic analysis of the seminal vesicle response to the reproductive toxicant acrylamide
Skerrett-Byrne, D. A., Nixon, B., Bromfield, E. G., Breen, J., Trigg, N. A., Stanger, S. J., Bernstein, I. R., Anderson, A. L., Lord, T., Aitken, R. J., et al. (2021) · BMC Genomics · doi:10.1186/s12864-021-07951-1 · Cited by 20
Prediction of a Missing Protein Expression Map in the Context of the Human Proteome Project
Guruceaga, E., del Pino, M. M. S., Corrales, F. J., & Segura, V. (2015) · Journal of Proteome Research · doi:10.1021/pr500850u · Cited by 19
Yang, J., Cheng, Z., Gong, F., & Fu, Y. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03662 · Cited by 19
Abdul-Khalek, N., Wimmer, R., Overgaard, M. T., & Echers, S. G. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.07.027 · Cited by 21
Spanish Human Proteome Project: Dissection of Chromosome 16
Segura, V., Medina-Auñón, J. A., Guruceaga, E., Gharbi, S., González-Tejedo, C., del Pino, M. M. S., Canals, F., Fuentes, M., Casal, J. I., Bartolomé, S., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300898u · Cited by 22
Bringing proteomics into the clinic: The need for the field to finally take itself seriously
Martens, L. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300020 · Cited by 19
The Mitochondrial Proteomic Signatures of Human Skeletal Muscle Linked to Insulin Resistance
Kruse, R., Sahebekhtiari, N., & Højlund, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155374 · Cited by 19
Deep-ultraviolet laser ablation sampling for proteomic analysis of tissue
Lawal, R. O., Richardson, L. T., Dong, C., Donnarumma, F., Solouki, T., & Murray, K. K. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339021 · Cited by 19
Chornoguz, O., Gapeev, A., O’Neill, M. C., & Ostrand‐Rosenberg, S. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.019232 · Cited by 20
“However, the analysis of complex peptide mixtures by mass spectrometry based proteomics has potential drawbacks such as under-sampling and limited dynamic range (31).”
BackgroundCancer metabolism: what we can learn from proteomic analysis by mass spectrometry.
Zhou, W., Liotta, L. A., & Petricoin, E. F. (2012) · PubMed · Cited by 23
Large Scale Proteomic Data and Network-Based Systems Biology Approaches to Explore the Plant World
Silvestre, D. D., Bergamaschi, A., Bellini, E. N., & Mauri, P. (2018) · Proteomes · doi:10.3390/proteomes6020027 · Cited by 22
From protein biomarkers to proteomics in dementia with Lewy Bodies
Tsamourgelis, A., Swann, P., Chouliaras, L., & O'Brien, J. T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101771 · Cited by 19
Medicinal Chemistry Meets Proteomics: Fractionation of the Human Plasma Proteome
Kovacs, A., & Guttman, A. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713804910111 · Cited by 18
Thygesen, C., Larsen, M. R., & Finsen, B. R. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1633919 · Cited by 20
“spectrometry-based proteomics has difficulties in identifyingmost cytokines and chemokines due to their small size [84] and low abundance, and these are therefore underrepresented in proteo-”
BackgroundBuilding Biomimetic Potency Tests for Islet Transplantation
Glieberman, A. L., Pope, B. D., Melton, D. A., & Parker, K. K. (2021) · Diabetes · doi:10.2337/db20-0297 · Cited by 19
Thompson, A., Abu, M., & Hanger, D. P. (2012) · Amino Acids · doi:10.1007/s00726-012-1287-x · Cited by 18
McDonagh, B., Domínguez-Martín, M. A., Gómez‐Baena, G., López‐Lozano, A., Díez, J., Bárcena, J. A., & García-Fernández, J. M. (2012) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2012.00329.x · Cited by 20
“This has a number of advantages over traditional shotgun proteomic techniques which can be prone to undersampling and can sometimes be overwhelmed by peptides that ionize and fragment well in MS/MS experiments, and for this reason there can be little overlap between MS runs (Malmstrom et al., 2007; Nilsson et al., 201…”
BackgroundMultidimensional Protein Identification Technology for Direct-Tissue Proteomics of Heart
Silvestre, D. D., Brambilla, F., & Mauri, P. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-386-2_3 · Cited by 19
Towards the analysis of protein species: an overview about strategies and methods
Jungblut, P. R., & Schlüter, H. (2011) · Amino Acids · doi:10.1007/s00726-010-0828-4 · Cited by 18
“(2) To develop new strategies and tools in the next years for the investigation of the proteome on the protein species level as well as to establish a higher degree of collaboration between cell biologists and proteomics specialists, although proteomics has reached highthroughput for the analysis of proteins and the c…”
BackgroundMethodMcQueen, P., Spicer, V., Schellenberg, J. J., Krokhin, O. V., Sparling, R., Levin, D. B., & Wilkins, J. A. (2014) · PROTEOMICS · doi:10.1002/pmic.201400188 · Cited by 17
Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review
Bradbury, M., Borràs, E., Pérez‐Benavente, A., Gil‐Moreno, A., Santamaría, A., & Sabidó, E. (2021) · Cancers · doi:10.3390/cancers13092067 · Cited by 17
“The recent technological developments in instrumentation, sample preparation, and data analysis have resulted in the availability of high-quality, reproducible and comprehensive data from a variety of clinical samples [60,61].”
BackgroundGolgi and Related Vesicle Proteomics: Simplify to IdentifyPreprint
Gannon, J., Bergeron, J. J. M., & Nilsson, T. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005421 · Cited by 17
“As described and thoroughly discussed in a recent commentary (Nilsson et al. 2010), mass spectrometry (MS)-based proteomics as currently deployed is correlative despite its high mass accuracy.”
BackgroundSelf-citationNicolardi, S., Palmblad, M., Hensbergen, P. J., Tollenaar, R. A. �. �., Deelder, A. M., & van der Burgt, Y. E. M. (2011) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.5246 · Cited by 16
“Thus, MS profiles can be highly reproducible provided each procedure in the workflow is carefully and correctly applied.([1]) In addition, matrix-assisted laser desorption/ionisation (MALDI)-MS of peptides remains unrivalled with respect to acquisition speed and automation strategies.”
MethodWang, F., Zhu, J., Hu, L., Qin, H., Ye, M., & Zou, H. (2012) · Protein & Cell · doi:10.1007/s13238-012-2934-4 · Cited by 16
McDonagh, B., Padilla, C. A., Pedrajas, J. R., & Bárcena, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193102 · Cited by 16
Detection of Missing Proteins Using the PRIDE Database as a Source of Mass Spectrometry Evidence
Garín-Muga, A., Odriozola, L., Martínez‐Val, A., del‐Toro, N., Martínez, R., Molina, M., Cantero, L., Rivera, R., Garrido, N., Domínguez, F., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00437 · Cited by 17
Serna, G., Ruiz-Pace, F., Cecchi, F., Fasani, R., Jimenez, J., Thyparambil, S., Landolfi, S., Elez, E., Vivancos, A., Hembrough, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49867-7 · Cited by 16
A community effort to identify and correct mislabeled samples in proteogenomic studies
Yoo, S., Shi, Z., Wen, B., Kho, S. J., Pan, R., Feng, H., Chen, H., Carlsson, A., Edén, P., Ma, W., et al. (2021) · Patterns · doi:10.1016/j.patter.2021.100245 · Cited by 16
“For every autosomal gene that exists in both RNA-seq and proteomic data, g , we compute its inter-omic correlation using Equation (1). where g ˛ OG : (Equation 1) Cor g istheinter-omiccorrelationofgene g , R g isthevectorofmRNAexpres-sion values of gene g across samples, while P g is the vector of protein expression v…”
BackgroundMethodInfluentialVelstra, B., van der Burgt, Y. E. M., Mertens, B. J. A., Mesker, W. E., Deelder, A. M., & Tollenaar, R. A. �. �. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1273-4 · Cited by 16
“Sample fractionation can overcome these issues and reduces the impact of under-sampling and improves reproducibility between analyses (Nilsson et al. 2010).”
BackgroundChallenges for proteomics core facilities
Lilley, K. S., Deery, M. J., & Gatto, L. (2011) · PROTEOMICS · doi:10.1002/pmic.201000693 · Cited by 16
“A recent article, however, suggests that proteomics is now ‘ready for the big time’ and provided that technologies are applied carefully and correctly, ensuing data can be highly informative and reproducible [16].”
BackgroundMessner, C. B., Demichev, V., Bloomfield, N., White, M. E. H., Kreidl, M., Ivosev, G., Wasim, F., Zelezniak, A., Lilley, K. S., Tate, S. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/656793 · Cited by 18
Jiang, Y., & Meyer, J. G. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00302 · Cited by 16
Noninvasive Biomarkers of Human Embryo Developmental Potential
Tesařík, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104928 · Cited by 16
“However, the use of high-throughput methodologies, such as mass spectrometry, eventually enhanced by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-ToF MS) [71], can make the analysis faster and more sensitive (Table 3).”
Pérez, V., Sánchez-Escuredo, A., Lauzurica, R., Bayés, B., Navarro-Muñoz, M., Pastor, M. C., Cañas, L., Bonet, J., & Romero, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.040 · Cited by 15
Identification of β-amyloid species in canine cerebrospinal fluid by mass spectrometry
Sarasa, L., Allué, J. A., Pesini, P., González‐Martínez, Á., & Sarasa, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.009 · Cited by 19
The Expanding Mi-2/NuRD Complexes: A Schematic Glance
Zhang, Y., & Li, Y. (2010) · Proteomics Insights · doi:10.4137/pri.s6329 · Cited by 17
Combining Percolator with X!Tandem for Accurate and Sensitive Peptide Identification
Xu, M., Li, Z., & Li, L. (2013) · Journal of Proteome Research · doi:10.1021/pr4001256 · Cited by 15
Proteogenomics in the context of the Human Proteome Project (HPP)
González-Gomariz, J., Guruceaga, E., López-Sánchez, M., & Segura, V. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1571916 · Cited by 15
Petzold, A., Bowser, R. P., Calabresi, P., Zetterberg, H., & Uitdehaag, B. M. J. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514524999 · Cited by 23
Giudice, G., Chen, H., Koutsandreas, T., & Petsalaki, E. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100771 · Cited by 15
“A limitation associated with using phosphoproteomics experiments is that they are intrinsically noisy, sparse, and lack reproducibility at the peptide level (13 – 18).”
BackgroundThe promise of targeted proteomics for quantitative network biology
Matsumoto, M., & Nakayama, K. I. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.02.014 · Cited by 14
Zhang, X., Šrot, V., Wu, X., Kern, K., van Aken, P. A., & Anggara, K. (2024) · Advanced Materials · doi:10.1002/adma.202310817 · Cited by 14
Benevento, M., & Muñoz, J. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.30 · Cited by 16
Huang, X., Liu, M., Nold, M. J., Tian, C., Fu, K., Zheng, J., Geromanos, S. J., & Ding, S. (2011) · Analytical Chemistry · doi:10.1021/ac201555m · Cited by 14
Nanocluster Isotope Distributions Measured by Electrospray Time-of-Flight Mass Spectrometry
Comeau, A. N., Liu, J., Khadka, C. B., Corrigan, J. F., & Konermann, L. (2012) · Analytical Chemistry · doi:10.1021/ac3031674 · Cited by 14
Hansmeier, N., Chao, T., Goldman, L. R., Witter, F. R., & Halden, R. U. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104190 · Cited by 14
“It has been employed successfully for a diverse range of organisms, tissues, and biofluids (Aebersold and Mann 2003; Ahrens et al. 2010a, 2010b; Beck et al. 2011; Domon and Aebersold 2010; Nilsson et al. 2010) and offers an ideal platform for fast identification of new protein markers for diseases or adverse exposure…”
BackgroundZhou, Y., Meng, Z., & Edman-Woolcott, M. (2015) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000378 · Cited by 14
“The dynamic concentration range of proteins in biological samples can reach eleven orders of magnitudes [5].”
BackgroundAbdul-Khalek, N., Picciani, M., Shouman, O., Wimmer, R., Overgaard, M. T., Wilhelm, M., & Gregersen Echers, S. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00973 · Cited by 13
“7 Moreover, variability in MS analysis is influenced by instrumental design 6 − 11 and downstream processes, such as the databases used for peptide and protein identity inference and the selected search engine, which can further exacerbate differences in the results.”
Proteomics appending a complementary dimension to precision oncotherapy
Zhou, Z., Zhang, R., Zhou, A., Lv, J., Chen, S., Zou, H., Zhang, G., Lin, T., Wang, Z., Zhang, Y., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.044 · Cited by 13
“The utilization of histology datasets in precision oncology is limited by elongated sample run durations, sophistication and ambulatory scope of proteomics samples, scarcity of inter-laboratory reproductive capacity, variation in quantitative methods, and other confounding factors[7,8 ] .”
MiTPeptideDB: a proteogenomic resource for the discovery of novel peptides
Guruceaga, E., Garín-Muga, A., & Segura, V. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz530 · Cited by 13
Yu, S., Yang, M., Xiong, J., Zhang, Q., Gao, X., Miao, W., & Ge, F. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00490-21 · Cited by 14
Prediction of Peptide Detectability Based on CapsNet and Convolutional Block Attention Module
Yu, M., Duan, Y., Li, Z., & Zhang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112080 · Cited by 13
“To be specific, protein detection and quantification are vital for gaining more insights into cell biology and human disease [1].”
BackgroundTowards a human proteomics atlas
Gonnelli, G., Hulstaert, N., Degroeve, S., & Martens, L. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5940-8 · Cited by 14
“Mass spectrometry-based proteomics has become a key tool in life sciences during the past few years [1].”
MethodJiang, L., Liu, Z., Zhaoyan, W., Su, Y., Yingjin, W., Wei, Y., Yanan, J., Jia, Z., Ma, C., Fangli, G., et al. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.08.035 · Cited by 13
A six-plex proteome quantification strategy reveals the dynamics of protein turnover
Wang, F., Cheng, K., Wei, X., Qin, H., Chen, R., Liu, J., & Zou, H. (2013) · Scientific Reports · doi:10.1038/srep01827 · Cited by 12
Kiel, C., Ebhardt, H. A., Burnier, J. V., Portugal, C., Sabidó, E., Zimmermann, T., Aebersold, R. H., & Serrano, L. G. (2013) · Journal of Proteome Research · doi:10.1021/pr400878x · Cited by 13
Self-citationBody Fluid Degradomics and Characterization of Basic N-Terminome
Sabino, F., Hermes, O., & Keller, U. A. D. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.09.018 · Cited by 12
Quantitative proteomics of model organisms
Feng, Y., Cappelletti, V., & Picotti, P. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.09.004 · Cited by 13
Themelis, T., Vos, J. D., Dores‐Sousa, J. L., Assche, T. R. C. V., & Eeltink, S. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128388 · Cited by 12
DbyDeep: Exploration of MS-Detectable Peptides via Deep Learning
Son, J., Na, S., & Paek, E. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c00460 · Cited by 11
Rawat, S., Jugran, A. K., & Sharma, H. (2024) · 3 Biotech · doi:10.1007/s13205-024-04006-6 · Cited by 11
Ultrahigh resolution profiles lead to more detailed serum peptidome signatures of pancreatic cancer
Nicolardi, S., Velstra, B., Mertens, B. J. A., Bonsing, B. A., Mesker, W. E., Tollenaar, R. A. �. �., Deelder, A. M., & van der Burgt, Y. E. M. (2013) · Translational Proteomics · doi:10.1016/j.trprot.2013.12.003 · Cited by 11
“Stage IA 7 [7] 7 [6] 7 2 [1] 2 [0] 0 IB 5 [3] 5 [3] 3 2 [2] 1 [1] 1 IIA 3 [2] 3 [1] 2 3 [1] 3 [0] 1 IIB 19 [13] 17 [14] 13 21 [18] 20 [17] 17 III 5 [3] 5 [4] 3 2 [2] 2 [2] 2 IV 7 [3] 8 [4] 5 9 [8] 7 [6] 6”
BackgroundInfluentialDirect digestion of proteins in living cells into peptides for proteomic analysis
Chen, Q., Yan, G., Gao, M., & Zhang, X. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8173-1 · Cited by 11
A systematic model of the LC-MS proteomics pipeline
Sun, Y., Braga-Neto, U., & Dougherty, E. R. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-s6-s2 · Cited by 11
“This is due to challenges in the candidate discovery and biomarker validation phases, such as the high dynamic range of proteins [5,6], the tandem MS under-sampling problem [6], peptide redundancy and signal interference in the mass-to-charge domain [7], and inaccurate quantification of proteins…”
BackgroundKonopka, A., Boehm, M. E., Rohmer, M., Baeumlisberger, D., Karas, M., & Lehmann, W. D. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6007-6 · Cited by 11
Cone snail Biology, Bioprospecting and Conservation
Dutertre, S., & Lewis, R. J. (2011) · HAL · doi:10.13140/2.1.3223.6489 · Cited by 11
Özdemir, V., Armengaud, J., Dubé, L., Aziz, R. K., & Knoppers, B. M. (2010) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/187569210793368230 · Cited by 11
“An independent paper, coinciding with the HPP proposal, further argued that the mass spectrometry, a significant driver of high-throughput proteomics analysis, has now advanced to a stage that can produce data with improved reproducibility and should be ready for such a large international project [18].”
Background
Metadata
- Authors
- Nilsson, T., Mann, M., Aebersold, R., Yates, J. R., Bairoch, A., & Bergeron, J. J. M.
- Affiliations
- Research Institute of the McGill University Health Centre (CA)
- Max Planck Society (DE)
- University of Zurich (CH)
- Scripps Research Institute (US)
- University of Geneva (CH)
- Corresponding author
- Nilsson, Tommy
- Bergeron, John J M
- Venue
- Nature Methods
- Published
- 2010-09
- Volume
- 7
- Issue
- 9
- Pages
- 681-685
- ISSN
- 1548-7091 (ISSN-L)
- 1548-7105
- OpenAlex
- W1975721281
- Cited by
- 470
- References
- 44
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 13 · 2023: 16 · 2022: 10 · 2021: 20 · 2020: 19 · 2019: 26 · 2018: 31 · 2017: 28 · 2016: 38 · 2015: 38 · 2014: 40 · 2013: 53 · 2012: 64
- FWCI
- 25.70
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- Locations
- Nature Methods (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- mass spectrometry, high-throughput proteomics, human proteome, proteome complexity
- MeSH terms
- Humans, Quality Control, Sensitivity and Specificity, Mass Spectrometry, Reproducibility of Results, Proteome, Databases, Protein, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.